Ajooni Biotech Limited (AJOONI) — Capital Reinvestment Ratio
Latest as of September 2025:
0.86x
Ajooni Biotech Limited (AJOONI) has a Capital Reinvestment Ratio of 0.86x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs135.46 Million) in capital expenditures (Rs117.15 Million). See AJOONI FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.86x
Capex / Operating Cash Flow
Operating Cash Flow
Rs135.46 Million
INR
Capital Expenditures
Rs117.15 Million
INR
Data as of
Sep 2025
Most recent filing
Ajooni Biotech Limited Capital Reinvestment Ratio (2015–2022)
This chart tracks Ajooni Biotech Limited's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Ajooni Biotech Limited (2015–2022)
Year-by-year Capital Reinvestment Ratio for Ajooni Biotech Limited from 2015 to 2022. For live market cap and broader valuation context, see Ajooni Biotech Limited (AJOONI) total market value.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.58x | Rs36.84 Million | Rs21.24 Million | ▼ -81.1% |
| 2021 | 3.05x | Rs11.56 Million | Rs35.27 Million | ▲ +122.8% |
| 2015 | 1.37x | Rs1.67 Million | Rs2.28 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow